Vaxcyte Inc (PCVX) — Financial Flexibility Index
Vaxcyte Inc (PCVX) has a Financial Flexibility Index of -1.30x as of June 2026. Free cash flow of $-493.73 Million (operating CF $-513.10 Million minus capex $19.37 Million) represents -1% of total liabilities ($380.21 Million). Check Vaxcyte Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vaxcyte Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Vaxcyte Inc across 9 annual periods. For the full cash flow conversion analysis, see PCVX cash generation efficiency.
Annual Financial Flexibility Index for Vaxcyte Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Vaxcyte Inc. Explore Vaxcyte Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.78x | $-641.86 Million | $-655.58 Million | $360.45 Million | ▲ +14.9% |
| 2024 | -2.09x | $-430.20 Million | $-452.63 Million | $205.50 Million | ▼ -53.1% |
| 2023 | -1.37x | $-228.91 Million | $-296.79 Million | $167.45 Million | ▲ +56.4% |
| 2022 | -3.13x | $-164.76 Million | $-170.60 Million | $52.56 Million | ▼ -10.0% |
| 2021 | -2.85x | $-114.84 Million | $-121.39 Million | $40.32 Million | ▼ -194.3% |
| 2020 | -0.97x | $-45.47 Million | $-46.63 Million | $46.98 Million | ▼ -262.4% |
| 2019 | -0.27x | $-45.95 Million | $-47.15 Million | $172.07 Million | ▼ -19.6% |
| 2018 | -0.22x | $-28.69 Million | $-30.47 Million | $128.53 Million | ▼ -14022.4% |
| 2017 | 0.00x | $-13.74K | $-14.96K | $8.69 Million | — |